Literature DB >> 26286760

Effects of bevacizumab loaded PEG-PCL-PEG hydrogel intracameral application on intraocular pressure after glaucoma filtration surgery.

Qian Han1, Yuqi Wang, Xiabin Li, Ribo Peng, Ailing Li, Zhiyong Qian, Ling Yu.   

Abstract

PEG-PCL-PEG (PECE) hydrogel for intracameral injection as a sustained delivery system can get a stable release of the medication and achieve an effective local concentration. The injectable PECE hydrogel is thermosensitive nano-material which is flowing sol at low temperature and can shift to nonflowing gel at body temperature. This study evaluated the intracameral injection of bevacizumab combined with a PECE hydrogel drug release system on postoperative scarring and bleb survival after experimental glaucoma filtration surgery. The best result was achieved in the bevacizumab loaded PECE hydrogels group, which presented the lowest IOP values after surgery. And the blebs were significantly more persistent in this group. Histology, Massion trichrome staining and immunohistochemistry further demonstrated that glaucoma filtration surgery in combination with bevacizumab loaded PECE hydrogel resulted in good bleb survival due to scar formation inhibition. In conclusions, this study demonstrated that bevacizumab-loaded PECE hydrogel for intracameral injection as a sustained delivery system provide a great opportunity to increase the therapeutic efficacy of glaucoma filtration surgery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26286760     DOI: 10.1007/s10856-015-5556-6

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  45 in total

1.  Corneal ectasia secondary to excessive ocular massage following trabeculectomy with 5-fluorouracil.

Authors:  R D Baldassare; I Brunette; D C Desjardins; M Amyot
Journal:  Can J Ophthalmol       Date:  1996-08       Impact factor: 1.882

2.  Late-onset bleb leaks after glaucoma filtering surgery.

Authors:  D S Greenfield; J M Liebmann; J Jee; R Ritch
Journal:  Arch Ophthalmol       Date:  1998-04

3.  The mechanism of vesicle fusion as revealed by molecular dynamics simulations.

Authors:  Siewert J Marrink; Alan E Mark
Journal:  J Am Chem Soc       Date:  2003-09-17       Impact factor: 15.419

4.  Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit.

Authors:  Farnaz Memarzadeh; Rohit Varma; Le-Tien Lin; Jignesh G Parikh; Laurie Dustin; Ana Alcaraz; Dean Eliott
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-31       Impact factor: 4.799

5.  Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.

Authors:  Naris Kitnarong; Panida Chindasub; Ankana Metheetrairut
Journal:  Adv Ther       Date:  2008-05       Impact factor: 3.845

6.  Alginate microsphere-collagen composite hydrogel for ocular drug delivery and implantation.

Authors:  Wenguang Liu; May Griffith; Fengfu Li
Journal:  J Mater Sci Mater Med       Date:  2008-06-11       Impact factor: 3.896

7.  Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.

Authors:  Zhongqiu Li; Tine Van Bergen; Sara Van de Veire; Isabelle Van de Vel; Huberte Moreau; Mieke Dewerchin; Prabhat C Maudgal; Thierry Zeyen; Werner Spileers; Lieve Moons; Ingeborg Stalmans
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-27       Impact factor: 4.799

8.  Toxicity evaluation of biodegradable and thermosensitive PEG-PCL-PEG hydrogel as a potential in situ sustained ophthalmic drug delivery system.

Authors:  HongBo Yin; ChangYang Gong; Shuai Shi; XuYang Liu; YuQuan Wei; ZhiYong Qian
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2010-01       Impact factor: 3.368

9.  Injectable thermosensitive PEG-PCL-PEG hydrogel/acellular bone matrix composite for bone regeneration in cranial defects.

Authors:  PeiYan Ni; QiuXia Ding; Min Fan; JinFeng Liao; ZhiYong Qian; JingCong Luo; XiuQun Li; Feng Luo; ZhiMing Yang; YuQuan Wei
Journal:  Biomaterials       Date:  2013-10-17       Impact factor: 12.479

10.  Preventing postoperative abdominal adhesions in a rat model with PEG-PCL-PEG hydrogel.

Authors:  Bing Yang; ChangYang Gong; Xia Zhao; ShengTao Zhou; ZhengYu Li; XiaoRong Qi; Qian Zhong; Feng Luo; ZhiYong Qian
Journal:  Int J Nanomedicine       Date:  2012-02-02
View more
  7 in total

Review 1.  Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.

Authors:  Jie Shen; Guang Wei Lu; Patrick Hughes
Journal:  Pharm Res       Date:  2018-09-25       Impact factor: 4.200

Review 2.  Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Authors:  Abhirup Mandal; Dhananjay Pal; Vibhuti Agrahari; Hoang My Trinh; Mary Joseph; Ashim K Mitra
Journal:  Adv Drug Deliv Rev       Date:  2018-01-13       Impact factor: 15.470

Review 3.  PCL-PEG copolymer based injectable thermosensitive hydrogels.

Authors:  Mithun Rajendra Dethe; Prabakaran A; Hafiz Ahmed; Mukta Agrawal; Upal Roy; Amit Alexander
Journal:  J Control Release       Date:  2022-01-25       Impact factor: 11.467

Review 4.  Glaucoma Treatment and Hydrogel: Current Insights and State of the Art.

Authors:  Antonio Maria Fea; Cristina Novarese; Paolo Caselgrandi; Giacomo Boscia
Journal:  Gels       Date:  2022-08-17

5.  Toxicity Assessment of PEG-PCCL Nanoparticles and Preliminary Investigation on Its Anti-tumor Effect of Paclitaxel-Loading.

Authors:  Wei Li; Wanyi Li; Yu Kuang; Ting Yang; Jie Zhu; Zilin Xu; Xiang Yuan; Mingyuan Li; Zhongwei Zhang; Yuan Yang
Journal:  Nanoscale Res Lett       Date:  2018-08-24       Impact factor: 4.703

Review 6.  Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems.

Authors:  Fidiniaina Rina Juliana; Samuel Kesse; Kofi Oti Boakye-Yiadom; Hanitrarimalala Veroniaina; Huihui Wang; Meihao Sun
Journal:  Molecules       Date:  2019-10-22       Impact factor: 4.411

Review 7.  Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review.

Authors:  Marcelo Luís Occhiutto; Raul C Maranhão; Vital Paulino Costa; Anastasios G Konstas
Journal:  Adv Ther       Date:  2019-12-10       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.